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The incidence of placenta accreta ranges from 1:2500 to 1:7000
births [1,2]. The incidence of placenta percreta has steadily
risen over the past several decades [3]. Although improvements
in documentation have occurred, an increase in patients with
relevant risk factors parallels the increase in incidence. Risk
factors for the development of abnormal placentation include:
previous cesarean deliveries, placenta previa, maternal age
greater than 35 years, high gravidity, multiparity, and previous
curettage [1,2].
A 34-year-old woman (gravida 6, para 1) presented for
evaluation with the diagnosis of a large vascular uterine mass, 4
months after having a dilation and curettage (D&C) for
completion of a first trimester miscarriage. At the time of her
D&C, she was at 8 weeks of gestation, and the quantitative beta-
human chorionic gonadotropin (βhCG) was 169,585 mIU/mL. The
patient's obstetric history was significant for a previous low
transverse cesarean delivery performed at 36 weeks secondary
to known vasa previa and bilobed placenta. Additionally, she had
undergone five prior D&Cs, for first trimester elective and
spontaneous abortions.
Pathologic evaluation following D&C showed products of
conception; however, the patient had persistent vaginal bleed-
ing. Serial transvaginal ultrasounds revealed a complex mass
seen in the anterior lower uterine segment. Magnetic resonance
imaging (MRI) revealed a large pelvic mass with areas of non-
enhancement consistent with possible necrosis (Fig. 1). The
mass abutted the right pelvic wall, bladder, and rectum, though
it did not clearly invade these structures. A computerized
tomography (CT) scan showed no adenopathy or extrauterine
masses.
Differential diagnosis at the time included placental site
trophoblastic tumor, persistent placental tissue, or other uterine
tumors including a degenerating fibroid. The patient was
counseled to undergo an examination under anesthesia, and
ultrasound-guided D&C. The βhCG at the time was 3 mIU/mL,
and serum human placental lactogen was b0.10 μg/mL. The
patient desired fertility preservation, but given the possibility of
myometrial invasion, the patient gave informed consent for
hysterectomy.
A D&C was attempted, however, sonographic guidance
revealed that the uterine mass was not clearly contiguous with
the endometrial cavity. Exploratory laparotomy was performed
which revealed an enlarged, necrotic, hemorrhagic mass
measuring 4×6 cm that protruded from the anterior lower
uterine segment, and was densely adhered to the bladder. Upon
attempted biopsy of the mass, a rapid loss of 500 cm3 of blood
occurred, resulting in a total abdominal hysterectomy. The
preliminary intraoperative pathology report was consistent with
necrosis and possible placental site trophoblastic tumor. Total
operative blood loss was 1000 cm3, and the patient's post-
operative course was unremarkable.
Final pathology revealed extensively necrotic placental
tissue extending from the anterior endometrial cavity, through
the myometrium to the uterine serosa (Fig. 2). The majority of
the placental tissue was extrauterine, consistent with necrotic
placenta percreta. In this case, the symptoms of persistent
vaginal bleeding and the development of a large vascular uterine
mass 4 months following a first trimester D&C were suggestive of
malignancy. This patient was at high risk of abnormal placenta-
tion, given her history of multiple uterine curettages and one
prior cesarean delivery.
Placenta percreta can lead to disastrous complications,
including uterine rupture, abolished future fertility, and even
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Figure 1 Gadolinium-enhanced T1-weighted MRI shows a
large anterior–uterine mass (arrow) adjacent to the right pelvic
sidewall, bladder, and rectum.
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death. The detection of placenta percreta in the first
trimester is very rare, and raises clinical questions regarding
the use of detailed imaging in high risk patients with
persistent bleeding. A search of the literature revealed only
a few other cases of placenta percreta at this early
gestational age. The correlation between placenta percreta
and patients with previous cesarean delivery and multiple
uterine curettages is significant. When evaluating patients
with persistent first trimester vaginal bleeding who have risk
factors for abnormal placentation, high clinical suspicion
should lead to prompt imaging studies to avoid the potential
catastrophic outcomes associated with placenta percreta.
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Figure 2 (A) Cross-section of uterus, revealing large vessels
and necrosis. (B) Bivalved uterine section, revealing anterior
uterine defect.
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